Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$482M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$460M |
| 3 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$294M |
| 4 |
Tesla
TSLA
|
+$276M |
| 5 |
Caterpillar
CAT
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01B |
| 3 |
Lowe's Companies
LOW
|
+$663M |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$404M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.68% |
| 2 | Healthcare | 6.62% |
| 3 | Financials | 5.53% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PORT
2751
DELISTED
Southport Acquisition Corporation
PORT
| $819K | ﹤0.01% |
80,457
-19,544
| -20% | -$197K |
|
2752
Encore Capital Group
ECPG
$2.02B
| $817K | ﹤0.01% |
17,052
+2,806
| +20% | +$135K |
|
2753
Pathward Financial
CASH
$1.86B
| $817K | ﹤0.01% |
18,979
+2,568
| +16% | +$105K |
|
2754
Upstart Holdings
UPST
$2.63B
| $815K | ﹤0.01% |
61,668
-22,255
| -27% | -$430K |
|
|
BLDP
2755
CALL
Ballard Power Systems
BLDP
$805M
| $813K | ﹤0.01% |
170,000
| – | – |
|
2756
Graham Holdings Company
GHC
$5.18B
| $813K | ﹤0.01% |
1,345
-385
| -22% | -$235K |
|
2757
Ambarella
AMBA
$3.77B
| $811K | ﹤0.01% |
9,868
-1,647
| -14% | -$110K |
|
2758
ARS Pharmaceuticals
SPRY
$509M
| $810K | ﹤0.01% |
95,014
+94,596
| +22,631% | +$614K |
|
2759
JFrog
FROG
$9.66B
| $810K | ﹤0.01% |
37,965
+2,338
| +7% | +$53.1K |
|
2760
Nurix Therapeutics
NRIX
$2.41B
| $808K | ﹤0.01% |
73,596
-46,922
| -39% | -$566K |
|
|
BDN
2761
Brandywine Realty Trust
BDN
$524M
| $808K | ﹤0.01% |
131,325
+4,525
| +4% | +$29.1K |
|
2762
First Commonwealth Financial
FCF
$2.18B
| $806K | ﹤0.01% |
57,702
+11,520
| +25% | +$162K |
|
2763
LSI Industries
LYTS
$859M
| $805K | ﹤0.01% |
65,787
+57,264
| +672% | +$573K |
|
2764
US Foods
USFD
$22.2B
| $804K | ﹤0.01% |
23,630
+6,444
| +37% | +$206K |
|
|
TLGY
2765
DELISTED
TLGY Acquisition Corporation Class A Ordinary Share
TLGY
| $803K | ﹤0.01% |
78,185
-229,016
| -75% | -$2.33M |
|
|
STEL
2766
DELISTED
Stellar Bancorp
STEL
| $802K | ﹤0.01% |
27,236
+5,174
| +23% | +$160K |
|
|
JBGS
2767
JBG SMITH
JBGS
$818M
| $802K | ﹤0.01% |
42,242
-25,800
| -38% | -$498K |
|
2768
Concentrix
CNXC
$1.5B
| $801K | ﹤0.01% |
6,018
-5,237
| -47% | -$636K |
|
2769
Flowserve
FLS
$9.71B
| $801K | ﹤0.01% |
26,097
-14,420
| -36% | -$421K |
|
|
SHUA
2770
DELISTED
SHUAA Partners Acquisition Corp I Class A Ordinary Share
SHUA
| $800K | ﹤0.01% |
77,665
| – | – |
|
2771
Seres Therapeutics
MCRB
$46.8M
| $799K | ﹤0.01% |
7,134
-2,404
| -25% | -$322K |
|
2772
Vanguard Materials ETF
VAW
$2.95B
| $799K | ﹤0.01% |
4,692
-540
| -10% | -$90.8K |
|
2773
Vanda Pharmaceuticals
VNDA
$307M
| $798K | ﹤0.01% |
108,034
-51,885
| -32% | -$505K |
|
2774
Shutterstock
SSTK
$198M
| $798K | ﹤0.01% |
15,132
+750
| +5% | +$38.2K |
|
2775
Takeda Pharmaceutical
TAK
$54.6B
| $798K | ﹤0.01% |
51,131
-891
| -2% | -$12.4K |
|
Similar funds
Citigroup's Q4 2022 Portfolio in Review
As of Q4 2022, Citigroup held 6,223 positions worth $126B, down 10% from $140B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Citigroup withdrew a net $21.4B in Q4 2022, closing 469 positions and reducing 2,674 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $404M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Consumer Staples Momentum ETF worth $21.5M.
- Citigroup's largest Q4 2022 buy was Invesco Dorsey Wright Consumer Staples Momentum ETF: 260,000 shares worth $21.5M.
- Citigroup added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2022, an estimated $482M increase.
- Citigroup's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.79B.
- Citigroup fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $404M.
- Citigroup's ten largest holdings make up 26% of its $126B portfolio in Q4 2022.
- Citigroup opened 309 new positions and closed 469 in Q4 2022.
- Citigroup's portfolio value fell 10% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.